News
Company ImmuPharma PLC
TIDM IMM
Headline Appointment of Joint Broker
Released 10:14 09-Oct-2009
Number 5242A10
FOR IMMEDIATE RELEASE
London, 9 October 2009
Appointment of Joint Broker
ImmuPharma plc (LSE:IMM), the specialist discovery and development pharmaceutical company is pleased to announce the appointment of Noble & Company Limited ("Noble") as its joint broker with immediate effect.
Commenting on Noble's appointment, Richard Warr, Chairman of ImmuPharma said: "We are delighted to have a team as committed as Noble working with us. Over the past months they have been instrumental in attracting blue-chip funds onto ImmuPharma's share register."
For further information please contact:
ImmuPharma PLC +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Tracy Weimar, Vice President, Operations
Buchanan Communications +44 20 7466 5000
Lisa Baderoon
Panmure Gordon & Co +44 151 243 0963
Andrew Burnett
Noble & Company Limited +44 20 7763 2200
James Bromhead
Sam Reynolds
© London Stock Exchange plc. All rights reserved